Mitochondrial Biomarkers in Huntington's Disease

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

April 4, 2019

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Huntington Disease
Interventions
DIAGNOSTIC_TEST

lumbar puncture

Some participants will have an optional lumbar puncture

Trial Locations (1)

44106

University Hospitals Cleveland Medical Center, Cleveland

All Listed Sponsors
collaborator

Case Western Reserve University

OTHER

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

The Cleveland Clinic

OTHER

lead

University Hospitals Cleveland Medical Center

OTHER

NCT04515550 - Mitochondrial Biomarkers in Huntington's Disease | Biotech Hunter | Biotech Hunter